Literature DB >> 12859189

Human arginase II: crystal structure and physiological role in male and female sexual arousal.

Evis Cama1, Diana M Colleluori, Frances A Emig, Hyunshun Shin, Soo Woong Kim, Noel N Kim, Abdulmaged M Traish, David E Ash, David W Christianson.   

Abstract

Arginase is a binuclear manganese metalloenzyme that catalyzes the hydrolysis of l-arginine to form l-ornithine and urea. The X-ray crystal structure of a fully active, truncated form of human arginase II complexed with a boronic acid transition state analogue inhibitor has been determined at 2.7 A resolution. This structure is consistent with the hydrolysis of l-arginine through a metal-activated hydroxide mechanism. Given that human arginase II appears to play a role in regulating l-arginine bioavailability to NO synthase in human penile corpus cavernosum smooth muscle, the inhibition of human arginase II is a potential new strategy for the treatment of erectile dysfunction [Kim, N. N., Cox, J. D., Baggio, R. F., Emig, F. A., Mistry, S., Harper, S. L., Speicher, D. W., Morris, S. M., Ash, D. E., Traish, A. M., and Christianson, D. W. (2001) Biochemistry 40, 2678-2688]. Since NO synthase is found in human clitoral corpus cavernosum and vagina, we hypothesized that human arginase II is similarly present in these tissues and functions to regulate l-arginine bioavailability to NO synthase. Accordingly, hemodynamic studies conducted with a boronic acid arginase inhibitor in vivo are summarized, suggesting that the extrahepatic arginase plays a role in both male and female sexual arousal. Therefore, arginase II is a potential target for the treatment of male and female sexual arousal disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12859189     DOI: 10.1021/bi034340j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

Review 1.  Endothelial arginase: a new target in atherosclerosis.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

2.  Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster.

Authors:  Luigi Di Costanzo; Michael E Pique; David W Christianson
Journal:  J Am Chem Soc       Date:  2007-05-01       Impact factor: 15.419

Review 3.  Arginase and vascular aging.

Authors:  Lakshmi Santhanam; David W Christianson; Daniel Nyhan; Dan E Berkowitz
Journal:  J Appl Physiol (1985)       Date:  2008-08-21

4.  Serum Arginase II level can be a novel indicator for erectile dysfunction in patients with vasculogenic erectile dysfunction: a comparative study.

Authors:  Abdel Shakour Abdel Hafez Abdel Wahed; Mohamed Abdel Mawgood Amer; Nagah Mohamed Abou Mohamed; Mohamed Ismael Mobasher; Hassan Mamdouh; Sameh Fayek GamalEl Din; Mohammed Said ElSheemy
Journal:  Int Urol Nephrol       Date:  2018-06-28       Impact factor: 2.370

5.  Binding of α,α-disubstituted amino acids to arginase suggests new avenues for inhibitor design.

Authors:  Monica Ilies; Luigi Di Costanzo; Daniel P Dowling; Katherine J Thorn; David W Christianson
Journal:  J Med Chem       Date:  2011-07-18       Impact factor: 7.446

Review 6.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

7.  2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I.

Authors:  Monica Ilies; Luigi Di Costanzo; Michelle L North; Jeremy A Scott; David W Christianson
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

8.  Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Amanda Roloson; Monica Ilies; Charles Perkins; William O'Brien; Stephen Cederbaum; David W Christianson; Nives Zimmermann; Marc E Rothenberg; Fred D Finkelman
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

9.  Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection .

Authors:  Daniel P Dowling; Monica Ilies; Kellen L Olszewski; Silvia Portugal; Maria M Mota; Manuel Llinás; David W Christianson
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

10.  Impact of substrate protonation and tautomerization states on interactions with the active site of arginase I.

Authors:  Shanthi Nagagarajan; Fengtian Xue; Alexander D MacKerell
Journal:  J Chem Inf Model       Date:  2013-01-31       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.